3D Printers - Made in India - Sold and Seviced in India

3D Priniters - Made in India

Novabean's Made in India, 3D printer for education UAVID 3D
http://www.novabeans.com/


http://www.cycloid.in/


3D Printers Starting from  Rs.19,999/-

Get your Designs 3D printed for Rs.5/min
http://www.3ding.in/3dprinters/#
http://www.huffingtonpost.in/ambika-choudhary-mahajan-/5-amazing-innovations-in-_b_6875748.html


Aha3D machines
Mind To Matter™
Founded in 2010 with a mission to carry out fundamental development on 3D printing technologies, and to serve as a platform for high technology indigenous research in this area. Certified for quality under ISO 9001:2008, Aha3D machines are uniquely evolved to bring true value in the Indian context, while offering globally competitive features.  Best in class 3D printers and Print services,

The core strength of the company is its in-house design and development specialization on all aspects of machine design, including embedded firmware, application software, core electronics and mechatronics. All the machines are fully designed in-house, and manufactured in India by our complementary network of manufacturing partners. In addition, we have a matching external consultants network in place, which ensure essential aspects like design for optimum manufacturing, ergonomics, and human factors of the machines.

Torch Bearers Of 3D Printing
Launched India’s first fully-indigenous 3D printer in March 2012.
Launched PrintProtect ™ for the first time in India.
Launched India’s first dual extrude printer with soluble support in Oct 2013.
Launched India’s largest and smartest FDM based printer in Feb 2015.

http://www.aha3d.in/index.php?id=about

aha!3D: The bootstrapped story of Jaipur-based industrial grade 3D printer makers
http://yourstory.com/2015/09/aha3d-3d-printers/

Global 3D Labs

Chocolate printing machine

http://www.3ders.org/articles/20150811-chocobot-is-the-first-made-in-india-commercial-chocolate-3d-printer.html


Divide by Zero is the manufacturer of FDM machines, specifically the Accucraft 3D printer.

While the technologies SLA and SLS were first to appear, FDM / FFF was able to grow in South Asian / Indian market due to the low price and better marketing. Even today they remain cheaper as compared to other technologies, both on the initial and running cost. After expiry of the key patents, FFF/FDM became available to anyone, which has led to its further reduction in price and availability as an open source machine. With more patents expiring, more technologies would move into this category.”

 “SLA, SLS and DMLS are all excellent production-worthy technologies which help build precise parts due to lower Z-heights. They are expensive as of now, and are growing in essential areas such as aerospace, automotive and medical industries. The game changer for these technologies will be the ability to reliably and efficiently manufacture end usable parts in medium size batches. DLP technology is young, but could be very disruptive. It has 3 main advantages of Price, Precision and Speed. DLP has only one limitation; that is its build size. There has been a rapid increase in the number of new machines using DLP, and we are looking out for the best performers in this space.”

hundreds of new startups coming up with 3D printing service bureau concepts,
http://3dprintingindustry.com/2015/11/25/62546/


3D Printing Service

Clarity 3D Printing is an advanced 3D printing service and is based in Mumbai, India. Send us your files and we will create 3D prototypes or even useable products using our 3D printing or additive manufacturing machines. We use high quality imported machines and plastic.

Bring your designs to life and get a real-life feel for products, buildings, handheld devices, and or anything else you can dream up.  These machines can create useable objects, not just working prototypes!
http://www.clarity3dprinting.com/


Altem Technologies - 3D Printing in Partnership with Stratasys
http://www.altem.com/3d-printing/



Stratasys Demonstration Center - Bengaluru, India - April 2015
http://www.thehindu.com/business/Industry/3d-printing-moving-to-mainstream/article7467217.ece

India - IoT - Products and Software Production and Sales

March 2016

23 March
Smartron  set to launch a slew of smart devices and Internet of Things (IoT) products for consumer and enterprise markets in the first quarter of 2016-17.  Smartron is headed by founder chairman Mahesh Lingareddy, co-founder and CEO of Soft Machines Inc, a United States based semiconductor company with operations in the US, India and Russia. It has research and development centres in Hyderabad and Bengaluru. Smartron will work in the areas of smart, sensor, robotics, artificial intelligence, cloud and big data technologies to bring next generation smart devices, services and care in consumer and industrial sector.
http://economictimes.indiatimes.com/tech/internet/sachin-tendulkar-invests-in-iot-firm-smartron-india/articleshow/51510078.cms

Indian Research for Breast Cancer Cure

For Triple Negative Breast Cancer (TNBC) the cost of treatment is Rs. 50,000 year. After relapse the cost can go up to Rs. 20 lakh.

Research conducted at Tata Memorial Hospital found on a pilot basis that low cost treatment can be used with good efficy. The cost comes to Rs, 2,700.



http://www.dnaindia.com/health/report-new-therapy-costing-rs-120-a-month-gives-hope-to-breast-cancer-patients-2184637



http://timesofindia.indiatimes.com/life-style/health-fitness/health-news/Rs-120-a-month-therapy-gives-breast-cancer-patients-hope/articleshow/51220423.cms


http://timesofindia.indiatimes.com/india/Rs-120-a-month-therapy-gives-breast-cancer-patients-hope/articleshow/51217993.cms

World’s cheapest smartphone named Freedom 251 in India

The Ringing bell freedom 251 is a smart phone with a quad-core processor, 1GB RAM, Android lollipop 5.1 and 8GB internal storage. It  is available for Rs. 251.


Freedom 251 bookings will be open on 18th of February at 6 am and close on 21st of February at 8 pm. Deliveries will be completed by 30th of June 2016.

www.freedom251.com
www.ringingbells.co.in

The smartphone Freedom 251 comes with a 1-year warranty, 6 months for Battery and Charger and also 3 months for Earphone commencing from the date of purchase.

Official Details of Ringing bells Company:

Official Website- www.ringingbells.co.in

Registered Office address- B-44, Sector 63, Noida – 201301

Contact numbers- 08822232323, 01204313087

Official E-mail- info@ringingbells.co.in


Both Economic Times and Times of India carried news items on this smart phone. They expressed doubt on how the company can supply at this low price. The other manufacturers request Ministry of Electronics to investigate and find out if there is any foul play in the offer.

Strategy to Sell Freedom Smart Phone at Rs. 251

How will the company manage to sell it at that price?

Ringing Bell claims it will be able to achieve this feat through four strategies.

Rs 2,500, is present cost of the device.

One, the benefit excise duty cuts by assembling handsets domestically would be Rs 400 or 16 per cent of Rs 2,500.

However, they are expecting from the government, which is at 13.8 per cent or Rs 55 lower than Rs 400.


Two, as it starts manufacturing in huge quantities (at least 500,000 units a month), it would be able to cut costs by a further Rs 500 a unit.

Three, online sales will help it cut costs by another Rs 500.

Four, it will have a specialised online platform, and earn additional revenue which is going fund the sasles of Freedom 251.

(http://www.rediff.com/business/report/alarm-bells-over-rs-251-smartphone-offer/20160219.htm)



21 Feb 2016

7.35 Crore Freedom 251 Phone Booked.
30,000 persons paid the full amount.
The company owner claimed that he will get the phone made at Rs. 220.  Shipping charges are collected separately. So there is margin for him. The present market price of the phone is Rs. 1719. But they decided the pricing because they wanted India to become Digital India Country
http://www.msn.com/en-in/news/techandscience/freedom-251-booking-closed-company-to-deliver-735-cr-phones-in-2016/ar-BBpJCzX?ocid=SK2MDHP



2017

The product got into problems and the whole sales campaign became a fiasco. Its present status is to be ascertained.


Updated 21 Feb 2016,  20 Feb 2016,  17 Feb 2016

Jeeto - 4 Wheeler Cargo Vehicle - Mahindra

Rs. 2.4 Lakhs Ex show room Thane

37.6 km/liter

Peeling the Corn - 2016

See the video shared on Facebook

The person is using a hand drill and a plastic piece to do the work effectively.

https://www.facebook.com/prabodh.halde/videos/1270940739588889/

Monoclonal Antibodies in India

mAbs in India


Biocon was the first Indian company to come up with its mAbs product, BIOMAb-EGFR (Nimotuzumab). The product was granted regulatory marketing and manufacturing approval in India in September 2006. The product is a therapeutic monoclonal antibody-based drug for treating solid tumors of epithelial origin, such as head and neck cancers.



 “In 2007, Dr Reddy's Labs came out with the novel concept of producing the biosimilar version of Rituximab, a version of Roche's cancer therapy, which could allow a greater access to the drug at half the price of the original. Reditux is the second product from Dr Reddy's Biologics Division, which is developing treatments for cancer and autoimmune diseases. The company has also launched the generic version of Amgen's Neupogen, and named it Grafeel.

Pune-based Serum Institute has entered into another agreement with Akorn of the US in 2007  for definitive development and exclusive distribution rights for rabies mAb.

Intas Biopharmaceuticals has signed a Memorandum of Understanding (MoU) with Government of Gujarat in 2009 for setting up a separate manufacturing facility for MAbs, a recombinant mammalian platform product. The company will invest Rs 160 crore towards setting up a manufacturing facility at Sanand near Ahmedabad. The facility, fully-dedicated for mAbs, will undertake large-scale manufacturing of the recombinant product with a capacity of 5000L in phases.

 Daftary group promoted Bharat Serums and Vaccines and Bangalore-based Avesthagen are some of the other notable companies that have chalked our serious plans for mABs.



“MAbs business involves patents and for navigating through these patents requires skills,”

Future prospects
By 2015 ,  the sales of mAbs is expected to reach Rs 3 lakh crore ($67.6 bn), with a CAGR of 13.8 percent between 2008 and 2015. The biotherapeutic market would be dominated with mAbs in next five years as most of the blockbuster molecules are going off-patented.

All the pharma majors have mAbs projects in their R&D portfolio. Introduction of newer monoclonal antibodies will greatly expand the market. Globally, the FDA had approved four new mAbs and EMA had approved seven new mAbs in 2009. There were at least six new mAbs under regulatory review, 26 mAbs (32 in 2008) are in phase III and over 100 are in phase II clinical trials. There are more than 150 mAbs molecule awaiting regulatory approval. I



Compared to India, China is a big market for mAbs. Some notable  companies include Union Stem Cell and Gene Engineering and Biotech pharmaceutical. In a serious effort towards innovation,China is moving towards areas like stem cells, mAbs, cancer and HIV development and vaccines with investments being pumped in both by the Government and foreign sources.

http://www.biospectrumindia.com/biospecindia/news/157328/monoclonal-antibodies-a-profitable-segment